Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy

This study paves the way for utilizing tumor-targeted protein degradation for precise anticancer therapy and the effective combination treatment of complex diseases.PMID:38609561 | DOI:10.1038/s41401-024-01266-z

Source: Acta Pharmacologica Sinica - April 12, 2024 Category: Drugs & Pharmacology Authors: Zhi-Feng Zou Lei Yang Hui-Jun Nie Jing Gao Shu-Min Lei Yi Lai Fan Zhang Ernst Wagner Hai-Jun Yu Xiao-Hua Chen Zhi-Ai Xu Source Type: research